Pharmacy Drugs
Recent Posts
- Beta Blockers May Increase Risk For Surgical Anemia Complications
- Alimera Announces Positive Results From The Two Phase 3 FAME(TM) Trials Of Iluvien(R) In Patients With Diabetic Macular Edema
- Lytix Biopharma AS Announces Regulatory Approval By Norwegian And Swedish Authorities To Commence Phase I Clinical Trial Of OncoporeTM In Cancer
- NPA Responds To Quality Accounts Consultation, UK
- Novelos Therapeutics’ (NVLT.OB) CEO Is Eyeing “Revolutionary” Phase III Study Results
Random Posts
- NCPA Statement On House Democrats' Bill On Health Care Reform
- Two New Clinical Studies Show That Limited Exposure To Blood Transfusion Significantly Increases Morbidity And Mortality After Surgery
- Mylan Again Calls For An End To Authorized Generics During 180-Day Exclusivity Period
- FDA Requires New Warnings for Testosterone Gels
- NovImmune Successfully Completes NI-0801 Phase I Clinical Study
- New York Times Examines Debate Surrounding Use Of Experimental Treatments In Terminally Ill Patients
- Results From 8 Late-Breaking Clinical Trials Presented At Heart Failure 2009
- Arena Pharmaceuticals Announces Merck Discontinues Development Of Investigational Niacin Receptor Agonist Program For Atherosclerosis
- NCPA To Congress: Health Reform Should Empower Community Pharmacies To Improve Patient Outcomes, Reduce Costs
- Galapagos Initiates Clinical Studies With GLPG0187, A Candidate Drug For Bone Metastasis
Mo. House Approves Amendment Allowing Pharmacies To Refuse To Stock EC, Medication Abortion Drugs
Posted by: admin in Pharmacy, Pharmacy Drugs on May 03rd, 2009
The Missouri House on Tuesday voted 115-43 to approve an amendment that would allow pharmacies to refuse to dispense emergency contraception or fill prescriptions, the Columbia Missourian reports. According to the Missourian, the bill specifically mentions the emergency contraceptive Plan B, which can prevent pregnancy if taken within 72 hours of sexual intercourse, and mifepristone, which is available by prescription only and used to induce abortion. Mifepristone is only available through a doctor and cannot be distributed by a pharmacy according to the Missourian.
The amendment, sponsored by state Rep. Ed Emery (R), prohibits lawsuits against pharmacies that do not carry the drugs and prevents the state from revoking the licenses of pharmacies that do not supply the medications. FDA recently announced that it would allow individuals ages 17 and older to purchase Plan B without a prescription (Wire, Columbia Missourian, 4/28). In addition, the amendment stipulates that pharmacies would not be required to advise people on how to obtain the medications. Current Missouri law does not address whether pharmacies must stock the drugs. According to the AP/Springfield News-Leader, Missouri’s Senate already approved the original bill (S.B 296), which involves professional licensing regulations.
Many Democrats objected to Emery’s amendment, arguing that the measure could hinder women’s access to EC, especially for women in rural areas (Blank, AP/Springfield News-Leader, 4/28). Some Democrats also said that the amendment is an attempt to control women’s bodies. “To implement a law like this, especially in a rural area, seems to me to put another road block before women,” state Rep. Mary Still (D) said. According to Emery, the measure is needed to protect pharmacy owners who object to stocking EC and mifepristone (Columbia Missourian, 4/28).
Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women’s Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women’s Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.
© 2009 The Advisory Board Company. All rights reserved.
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.